Strategies to induce broadly protective antibody responses to viral glycoproteins

Strategies to induce broadly protective antibody responses to viral glycoproteins

Introduction: Currently, several universal/broadly protective influenza virus vaccine candidates are under development. Many of these vaccines are based on strategies to induce protective antibody responses against the surface glycoproteins of antigenically and genetically diverse influenza viruses....

Full description

Bibliographic Details
Main Author:	F Krammer
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-05-01
Series:	Expert Review of Vaccines
Subjects:	influenza universal vaccine viral glycoproteins filovirus arenavirus hcv hiv conserved epitope heterosubtypic immunity hemagglutinin
Online Access:	http://dx.doi.org/10.1080/14760584.2017.1299576

Similar Items

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
by: Sushmita Kumari, et al.
Published: (2022-08-01)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
by: Wen-Chun Liu, et al.
Published: (2019-04-01)

Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus
by: Jin Il Kim1,2,#, Ilseob Lee1,2,#, Sehee Park1,2,# & Man-Seong Park1,2,*
Published: (2012-11-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
by: Pedro M. Folegatti, et al.
Published: (2019-03-01)

Animal Models for Influenza Viruses: Implications for Universal Vaccine Development
by: Irina Margine, et al.
Published: (2014-10-01)

Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
by: Kaito A. Nagashima, et al.
Published: (2021-03-01)

A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
by: Yuting Zhang, et al.
Published: (2024-03-01)

Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
by: Mark B. Carascal, et al.
Published: (2022-06-01)

Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
by: Mark B. Carascal, et al.
Published: (2022-05-01)

Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine
by: Xuejie Liu, et al.
Published: (2022-09-01)

Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice
by: Sally Sarawar, et al.
Published: (2022-12-01)

Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge
by: Lindsay Hill-Batorski, et al.
Published: (2023-04-01)

Induction of cross-reactive antibodies in mice immunized with conserved influenza A virus neuraminidase-derived linear B-cell epitopes
by: I. A. Sychev, et al.
Published: (2021-06-01)

Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem
by: Christy Ann Thomson, et al.
Published: (2012-05-01)

CROSSREACTIVE ANTIBODIES AND MEMORY T CELLS TO HUMAN AND ZOONOTIC INFLUENZA A VIRUSES IN VOLUNTEERS
by: I. V. Losev, et al.
Published: (2015-10-01)

Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses
by: Chenchen Jiao, et al.
Published: (2023-02-01)

Exploring the Mumps Virus Glycoproteins: A Review
by: Jasmine Rae Frost, et al.
Published: (2022-06-01)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
by: Philip Meade, et al.
Published: (2020-02-01)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
by: Katherine A. Willard, et al.
Published: (2018-12-01)

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
by: Limin Zhang, et al.
Published: (2022-08-01)

HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS
by: A. R. Rekstin, et al.
Published: (2014-07-01)

HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS
by: A. R. Rekstin, et al.
Published: (2014-07-01)

Identification and In Silico Characterization of a Conserved Peptide on Influenza Hemagglutinin Protein: A New Potential Antigen for Universal Influenza Vaccine Development
by: Atin Khalaj-Hedayati, et al.
Published: (2023-10-01)

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
by: Alyse D. Portnoff, et al.
Published: (2020-02-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)

The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers
by: A. A. Petrov, et al.
Published: (2015-06-01)

H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
by: Juan Manuel Carreño, et al.
Published: (2020-12-01)

The Next Generation of Influenza Vaccines: Towards a Universal Solution
by: Christopher L.D. McMillan, et al.
Published: (2021-01-01)

Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice
by: Daniel A. J. Mitchell, et al.
Published: (2017-12-01)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
by: Claudia Gandolfo, et al.
Published: (2021-08-01)

A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
by: J. Maximilian Fels, et al.
Published: (2019-08-01)

Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails
by: B Farahmand, et al.
Published: (2017-05-01)

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
by: Kizzmekia S. Corbett, et al.
Published: (2019-02-01)

Biomimetic nanoparticles as universal influenza vaccine
by: Fengyuan Wang, et al.
Published: (2020-01-01)

Etymologia: Hemagglutinin and Neuraminidase
by: Ronnie Henry, et al.
Published: (2018-10-01)

Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection
by: Zackery A. G. Knowlden, et al.
Published: (2019-11-01)

Designing of A Multi-epitope Recombinant Protein, Consisting of Several Conserved Epitopes from Hemagglutinin Protein of the H1N1 and H5N1 Strains of Influenza Virus by Immunoinformatics Approaches
by: Farnaz Moghaddam, et al.
Published: (2020-10-01)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
by: Wenjun Zhu, et al.
Published: (2019-10-01)

In silico-based vaccine design against Ebola virus glycoprotein
by: Dash R, et al.
Published: (2017-03-01)

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates
by: Nuno Taveira, et al.
Published: (2023-05-01)